ResMed Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RME.F | FPH.NZ | KMTS | MMSI | AHC.AX | BVC.L | |
|---|---|---|---|---|---|---|
| Market cap | 29.90B | 28.57B | 1.82B | 5.43B | 103.06M | 39.11M |
| P/E (TTM) | 22.5 | 60.7 | — | 33.9 | 13.8 | — |
| Forward P/E | 32.3 | 44.4 | -14.8 | 19.4 | 7.9 | 22.0 |
| Price/book | 5.6 | 13.5 | 8.1 | 3.1 | 1.7 | 0.8 |
| Dividend yield | 1.18% | 1.13% | — | — | — | — |
| 1-year change | −5.88% | +23.84% | +16.86% | +4.76% | −38.98% | −31.89% |
| Today | +0.76% | +3.87% | +5.14% | +7.69% | +1.85% | +4.55% |
The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 20 min.
Latest news
All RME.F news ›Buy, hold, sell: ResMed, Origin Energy, Reece shares
A broker has had its say on these three shares. Cameron England is a business reporter with more than 20 years of experience covering Australian business, ASX-listed companies, corporate governance, and financial markets. His reporting…
ResMed (ASX:RMD): Can This ASX 200 Med-Tech Leader Keep Its Momentum?
ResMed operates in sleep and respiratory care devices. That operating identity matters because the market is separating businesses with visible demand from those relying on a broad improvement in sentiment. The current share-price response…
ResMed Inc. Declares Ordinary Dividend for the Quarter Ended September 30, 2026, Payable on December 17, 2026
ResMed Inc. declared ordinary dividend of $0.66 per share for the quarter ended September 30, 2026. The dividend is payable on December 17, 2026 with record date of November 12, 2026 and ex-date of... Published on 10/29/2026 at 05:13 pm…
ResMed (NYSE:RMD) Stock Rating Cut to Hold at Canaccord Genuity Group
ResMed (NYSE:RMD - Get Free Report) was downgraded by Canaccord Genuity Group from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Monday, Briefing.com reports. Get Our Latest Report on ResMed…
Citigroup Adjusts Price Target on ResMed to $270 From $240
ResMed has an average rating of overweight and mean price target of $272.20, according to analysts polled by FactSet. ... Advanced Medical Equipment & Technology Citigroup Adjusts Price Target on ResMed to $270 From $240 Published on…
RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating
ResMed has an average rating of overweight and mean price target of $272.24, according to analysts polled by FactSet. ... Advanced Medical Equipment & Technology RBC Raises Price Target on ResMed to $288 From $262, Keeps Outperform Rating…
What Sent ResMed Stock Lower?
Shares of ResMed (RMD) fell 9.1% on Friday, October 30, 2026, while the S&P 500 lost 1.8%. The decline came the day after the release of ResMed’s fiscal first-quarter 2027 results on October 29. The other companies on its peer list also…
ResMed (NYSE:RMD) Stock Gets Price Target Bump from KeyCorp
ResMed (NYSE:RMD - Get Free Report) had its price target boosted by equities research analysts at KeyCorp from $267.00 to $277.00 in a research note issued to investors on Friday, Benzinga reports. The firm currently has an "overweight"…
ResMed (NYSE:RMD) Price Target Raised to $288.00
Check Out Our Latest Research Report on ResMed Here are the key news stories impacting ResMed this week: ResMed Inc is a medical equipment and software company that develops solutions for sleep-disordered breathing, respiratory conditions…
RESMED ($RMD) Releases Q1 2027 Earnings
RESMED ($RMD) posted quarterly earnings results for Q1 2027 on Thursday, October 29th. The company reported earnings of $2.91 per share, beating estimates of $2.70 by $0.21. The company also reported revenue of $1,414,810,000, beating…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com18
- kalkinemedia.com7
- marketbeat.com7
- seekingalpha.com6
- fool.com.au5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 71 articles, not a forecast.